This systematic review aims to update on the prevalence of odontogenic-related infections and the efficacy of dental strategies in preventing dental-related complications in cancer patients since the 2010 systematic review.
A literature search was conducted in the databases MEDLINE/PubMed and EMBASE for articles published between 1 January 2009 and 30 June 2016. Each study was assessed by 2 reviewers and the body of evidence for each intervention was assigned an evidence level.
After examination of the abstracts and full-text articles, 59 articles satisfied the inclusion criteria. The weighted prevalence of dental infections and pericoronitis during cancer therapy was 5.4 and 5.3%, respectively. The frequency of dental-related infections during intensive chemotherapy after complete, partial, and minimal pre-cancer dental evaluation/treatment protocols ranged from 0 to 4%. Protocols involving third molars extractions had the highest complications (40%).
In view of the low prevalence of infections and the potential for complications after third molar extractions, it is suggested that partial dental evaluation/treatment protocols prior to intensive chemotherapy; whereby minor caries (within dentin), asymptomatic third molars or asymptomatic teeth without excessive probing depth (<8 mm), mobility (mobility I or II) or with periapical lesions of <5 mm were observed; is a viable option when there is insufficient time for complete dental evaluation/treatment protocols. The use of chlorhexidine, fluoride mouth rinses as well as composite resin, resin-modified glass ionomer cement (GIC), and amalgam restorations over conventional GIC in post head and neck radiation patients who are compliant fluoride users is recommended.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Collins FS, Varmus H (2015) A new initiative on precision medicine. N Engl J Med 372(9):793–795. doi:10.1056/NEJMp1500523
Institute NC (Asesssed 25th May 2016) Oral complications of chemotherapy and head /neck radiation
Hong CH, Napenas JJ, Hodgson BD, Stokman MA, Mathers-Stauffer V, Elting LS, Spijkervet FK, Brennan MT, Dental Disease Section OCSGM-nAoSCiCISoOO (2010) A systematic review of dental disease in patients undergoing cancer therapy. Support Care Cancer 18(8):1007–1021. doi:10.1007/s00520-010-0873-2
Graber CJ, de Almeida KN, Atkinson JC, Javaheri D, Fukuda CD, Gill VJ, Barrett AJ, Bennett JE (2001) Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 27(5):537–542. doi:10.1038/sj.bmt.1702818
Lark RL, McNeil SA, VanderHyde K, Noorani Z, Uberti J, Chenoweth C (2001) Risk factors for anaerobic bloodstream infections in bone marrow transplant recipients. Clin Infect Dis 33(3):338–343. doi:10.1086/322595
Gibson F (2004) Best practice in oral care for children and young people being treated for cancer: can we achieve consensus? Eur J Cancer 40(8):1109–1110. doi:10.1016/j.ejca.2004.02.008
Glenny AM, Gibson F, Auld E, Coulson S, Clarkson JE, Craig JV, Eden OB, Worthington HV, Pizer B, Group U-PMC (2004) A survey of current practice with regard to oral care for children being treated for cancer. Eur J Cancer 40(8):1217–1224. doi:10.1016/j.ejca.2004.01.030
Bueno AC, Ferreira RC, Barbosa FI, Jham BC, Magalhaes CS, Moreira AN (2013) Periodontal care in patients undergoing radiotherapy for head and neck cancer. Support Care Cancer 21(4):969–975. doi:10.1007/s00520-012-1614-5
Schuurhuis JM, Stokman MA, Roodenburg JL, Reintsema H, Langendijk JA, Vissink A, Spijkervet FK (2011) Efficacy of routine pre-radiation dental screening and dental follow-up in head and neck oncology patients on intermediate and late radiation effects. A retrospective evaluation. Radiother Oncol 101(3):403–409. doi:10.1016/j.radonc.2011.09.018
Cankar K, Finderle Z, Jan J (2011) The effect of hyperbaric oxygenation on postradiation xerostomia and saliva in patients with head and neck tumours. Caries Res 45(2):136–141. doi:10.1159/000324811
Sommerfield MRPJ, Pfister DG, Bennett CL, Recht A, Smith TJ, Weeks JC, Winn RJ, Durant JR (2000) ASCO clinical practice guidelines: process, progress, pitfalls, and prospects. Class Pap Curr Comments 4:881–886
Hadorn DC, Baker D, Hodges JS, Hicks N (1996) Rating the quality of evidence for clinical practice guidelines. J Clin Epidemiol 49(7):749–754
Ardizzoni A, Pennucci MC, Danova M, Viscoli C, Mariani GL, Giorgi G, Venturini M, Mereu C, Scolaro T, Rosso R (1996) Phase I study of simultaneous dose escalation and schedule acceleration of cyclophosphamide-doxorubicin-etoposide using granulocyte colony-stimulating factor with or without antimicrobial prophylaxis in patients with small-cell lung cancer. Br J Cancer 74(7):1141–1147
Baliga AM, Brave VR, Vyas HA (1995) Oral mucosal lesions in patients with acute leukemias and related disorders due to cytotoxic therapy. J Indian Soc Pedod Prev Dent 13(1):25–29
Fayle SA, Curzon ME (1991) Oral complications in pediatric oncology patients. Pediatr Dent 13(5):289–295
Toljanic JA, Bedard JF, Larson RA, Fox JP (1999) A prospective pilot study to evaluate a new dental assessment and treatment paradigm for patients scheduled to undergo intensive chemotherapy for cancer. Cancer 85(8):1843–1848
El-Housseiny AA, Saleh SM, El-Masry AA, Allam AA (2007) Assessment of oral complications in children receiving chemotherapy. J Clin Pediatr Dent 31(4):267–273
Schuurhuis JM, Span LF, Stokman MA, van Winkelhoff AJ, Vissink A, Spijkervet FK (2016) Effect of leaving chronic oral foci untreated on infectious complications during intensive chemotherapy. Br J Cancer 114(9):972–978. doi:10.1038/bjc.2016.60
Gurgan CA, Ozcan M, Karakus O, Zincircioglu G, Arat M, Soydan E, Topcuoglu P, Gurman G, Bostanci HS (2013) Periodontal status and post-transplantation complications following intensive periodontal treatment in patients underwent allogenic hematopoietic stem cell transplantation conditioned with myeloablative regimen. Int J Dent Hyg 11(2):84–90. doi:10.1111/j.1601-5037.2012.00550.x
Haytac MC, Dogan MC, Antmen B (2004) The results of a preventive dental program for pediatric patients with hematologic malignancies. Oral Health Prev Dent 2(1):59–65
Melkos AB, Massenkeil G, Arnold R, Reichart PA (2003) Dental treatment prior to stem cell transplantation and its influence on the posttransplantation outcome. Clin Oral Investig 7(2):113–115. doi:10.1007/s00784-003-0209-4
Raut A, Huryn JM, Hwang FR, Zlotolow IM (2001) Sequelae and complications related to dental extractions in patients with hematologic malignancies and the impact on medical outcome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92(1):49–55. doi:10.1067/moe.2001.113588
Tai CC, Precious DS, Wood RE (1994) Prophylactic extraction of third molars in cancer patients. Oral Surg Oral Med Oral Pathol 78(2):151–155
Tsuji K, Shibuya Y, Akashi M, Furudoi S, Yakushijin K, Kawamoto S, Okamura A, Matsuoka H, Komori T (2015) Prospective study of dental intervention for hematopoietic malignancy. J Dent Res 94(2):289–296. doi:10.1177/0022034514561768
Yamagata K, Onizawa K, Yanagawa T, Hasegawa Y, Kojima H, Nagasawa T, Yoshida H (2006) A prospective study to evaluate a new dental management protocol before hematopoietic stem cell transplantation. Bone Marrow Transplant 38(3):237–242. doi:10.1038/sj.bmt.1705429
Yamagata K, Onizawa K, Yanagawa T, Takeuchi Y, Hasegawa Y, Chiba S, Bukawa H (2011) Prospective study establishing a management plan for impacted third molar in patients undergoing hematopoietic stem cell transplantation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111(2):146–152. doi:10.1016/j.tripleo.2010.09.006
Yamagata K, Onizawa K, Yoshida H, Yamagata K, Kojima Y, Koike K, Tsuchida M (2006) Dental management of pediatric patients undergoing hematopoietic stem cell transplant. Pediatr Hematol Oncol 23(7):541–548. doi:10.1080/08880010600814187
Dholam KP, Somani PP, Prabhu SD, Ambre SR (2013) Effectiveness of fluoride varnish application as cariostatic and desensitizing agent in irradiated head and neck cancer patients. Int J Dent 2013:824982. doi:10.1155/2013/824982
Thariat J, Ramus L, Darcourt V, Marcy PY, Guevara N, Odin G, Poissonnet G, Castillo L, Ali AM, Righini C (2012) Compliance with fluoride custom trays in irradiated head and neck cancer patients. Support Care Cancer 20(8):1811–1814. doi:10.1007/s00520-011-1279-5
Meca LB, Souza FR, Tanimoto HM, Castro AL, Gaetti-Jardim Junior E (2009) Influence of preventive dental treatment on mutans streptococci counts in patients undergoing head and neck radiotherapy. J Appl Oral Sci 17(Suppl):5–12
Pattni R, Walsh LJ, Marshall RI, Cullinan MP, Seymour GJ, Bartold PM (2000) Changes in the periodontal status of patients undergoing bone marrow transplantation. J Periodontol 71(3):394–402. doi:10.1902/jop.2000.71.3.394
De Moor RJ, Stassen IG, van’t Veldt Y, Torbeyns D, Hommez GM (2011) Two-year clinical performance of glass ionomer and resin composite restorations in xerostomic head- and neck-irradiated cancer patients. Clin Oral Investig 15(1):31–38. doi:10.1007/s00784-009-0355-4
McComb D, Erickson RL, Maxymiw WG, Wood RE (2002) A clinical comparison of glass ionomer, resin-modified glass ionomer and resin composite restorations in the treatment of cervical caries in xerostomic head and neck radiation patients. Oper Dent 27(5):430–437
Wood RE, Maxymiw WG, McComb D (1993) A clinical comparison of glass ionomer (polyalkenoate) and silver amalgam restorations in the treatment of Class 5 caries in xerostomic head and neck cancer patients. Oper Dent 18(3):94–102
Al-Nawas B, Grotz KA (2006) Prospective study of the long term change of the oral flora after radiation therapy. Support Care Cancer 14(3):291–296. doi:10.1007/s00520-005-0895-3
Almstahl A, Wikstrom M, Fagerberg-Mohlin B (2008) Microflora in oral ecosystems in subjects with radiation-induced hyposalivation. Oral Dis 14(6):541–549. doi:10.1111/j.1601-0825.2007.01416.x
Beer KT, Zehnder D, Lussi A, Greiner RH (2002) Sparing of contralateral major salivary glands has a significant effect on oral health in patients treated with radical radiotherapy of head and neck tumors. Strahlenther Onkol 178:722–6
Leung WK, Jin LJ, Samaranayake LP, Chiu GK (1998) Subgingival microbiota of shallow periodontal pockets in individuals after head and neck irradiation. Oral Microbiol Immunol 13(1):1–10
Meng L, Liu J, Peng B, Fan M, Nie M, Chen Z, Gan Y, Bian Z (2005) The persistence of Streptococcus mutans in nasopharyngeal carcinoma patients after radiotherapy. Caries Res 39(6):484–489. doi:10.1159/000088184
Srithavaj T, Thaweboon S (2006) Determination of oral microflora in irradiated ocular deformed children. Southeast Asian J Trop Med Public Health 37(5):991–995
Dens F, Boogaerts M, Boute P, Declerck D, Demuynck H, Vinckier F, Belgium B (1996) Caries-related salivary microorganisms and salivary flow rate in bone marrow recipients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81(1):38–43
Jensen SB, Mouridsen HT, Bergmann OJ, Reibel J, Brunner N, Nauntofte B (2008) Oral mucosal lesions, microbial changes, and taste disturbances induced by adjuvant chemotherapy in breast cancer patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106(2):217–226. doi:10.1016/j.tripleo.2008.04.003
Kang MS, Oh JS, Jeong KY, Kim HJ, Lee JJ, Lee GS, Lim HJ, Lim HS (2013) Analysis of cariogenic bacteria in saliva of cancer patients. Chonnam Med J 49(2):75–80. doi:10.4068/cmj.2013.49.2.75
Meurman JH, Laine P, Lindqvist C, Teerenhovi L, Pyrhonen S (1997) Five-year follow-up study of saliva, mutans streptococci,lactobacilli and yeast counts in lymphoma patients. Oral Oncol 33(6):439–443
O’Sullivan EA, Duggal MS, Bailey CC, Curzon ME, Hart P (1993) Changes in the oral microflora during cytotoxic chemotherapy in children being treated for acute leukemia. Oral Surg Oral Med Oral Pathol 76(2):161–168
Ou-Yang LW, Chang PC, Tsai AI, Jaing TH, Lin SY (2010) Salivary microbial counts and buffer capacity in children with acute lymphoblastic leukemia. Pediatr Dent 32(3):218–222
Zhang J, Liu H, Liang X, Zhang M, Wang R, Peng G, Li J (2015) Investigation of salivary function and oral microbiota of radiation caries-free people with nasopharyngeal carcinoma. PLoS One 10(4):e0123137. doi:10.1371/journal.pone.0123137
Olszewska K, Mielnik-Blaszczak M (2016) An assessment of the number of cariogenic bacteria in the saliva of children with chemotherapy-induced neutropenia. Adv Clin Exp Med 25(1):11–19. doi:10.17219/acem/28998
Meurman JH, Laine P, Lindqvist C, Teerenhovi L, Pyrhonen S (1997) Five-year follow-up study of saliva, mutans streptococci, lactobacilli and yeast counts in lymphoma patients. Oral Oncol 33(6):439–443
Allareddy V, Prakasam S, Allareddy V, Martinez-Schlurmann NI, Rampa S, Nalliah RP, Eswaran SV, Elangovan S (2015) Poor oral health linked with increased risk of infectious complications in adults with leukemia. J Mass Dent Soc 64(3):38–42
The authors thank Ms. Sim Yu Fan for helping with the statistical analyses for this manuscript. We would like to also thank Dr. Sharon Tan for assisting with the data management.
Conflict of interest
The authors declare that they have no conflict of interest.
About this article
Cite this article
Hong, C.H.L., Hu, S., Haverman, T. et al. A systematic review of dental disease management in cancer patients. Support Care Cancer 26, 155–174 (2018). https://doi.org/10.1007/s00520-017-3829-y
- Dental caries
- Periodontal disease
- Anti-neoplastic agents
- Hematopoietic stem cell transplantation